A group of independent advisors to the U.S. Food and Drug Administration endorsed the monoclonal antibody nirsevimab, which protects infants from respiratory syncytial virus
View Reddit by DoremusJessup – View Source
First in the Morning
A group of independent advisors to the U.S. Food and Drug Administration endorsed the monoclonal antibody nirsevimab, which protects infants from respiratory syncytial virus